Aenova unites pharma, consumer healthcare sales

Aenova unites pharma, consumer healthcare sales

Aenova, Europe's leading manufacturer of medicines and dietary supplements, is bringing all its sales channels together under one roof. Bernd Ehlert, who was previously head of the pharmaceutical sales business unit, will manage the combined sales team.

With the aim of optimising its sales structure, Aenova, Europe¹s leading
manufacturer of medicines and dietary supplements, is bringing all its sales
channels together under one roof. Bernd Ehlert, who was previously head of
the pharmaceutical sales business unit, will manage the combined sales team.

Until now, the Aenova Group¹s sales function has been divided into two
areas: pharmaceutical and consumer healthcare. As a result of changes in
market conditions and the requirements of customers, who often have both
medicines and dietary supplements in their product portfolio, the two sales
teams are being combined. There is no longer any need for the different
sales segments to be separated. Customers of the Aenova Group will benefit
from a faster and improved service. In addition, Aenova will be able to
speed up its internal processes and exploit synergies.

On 1 February 2012, Bernd Ehlert has taken on responsibility for sales
throughout the Aenova Group. Until now, the new director of sales has been
head of the pharmaceutical sales team. As part of this reorganisation, Dr.
Wolfgang Jahn, who has for many years managed the consumer healthcare sales
department, will be leaving the company. Customers of the company will find
that their usual sales contacts are unchanged.

About Aenova

Aenova Holding GmbH was established in 2008 following the merger between two
prominent medium-sized companies: Dragenopharm Apotheker Püschl GmbH and
SWISS CAPS AG. The Aenova Group is now one of the leading manufacturers and
suppliers of medicines and dietary supplements in oral dosage forms, such as
soft gelatine capsules, hard capsules, tablets, film-coated tablets, dragées
and effervescent tablets for the pharmaceutical and healthcare industry. The
group has an annual turnover of around EUR 250 million and employs 1500
people at its sites in Germany (Tittmoning, Berlin, Bad Aibling and
Warstein), Switzerland (Kirchberg, Muttenz and Bioggio), France (Lyons),
Romania (Cornu) and the USA (Miami). The Aenova Group, which has its
headquarters in Pähl, offers its customers a complete portfolio of services,
ranging from development, procurement of raw materials, production and
analysis through to packaging and logistics.

For further press information, please contact:

Söllner Communications AG
Kathrin Shuey
Rosenkavalierplatz 5
81925 Munich
Tel.: +49 (0)89 41 94 73 13
Fax: +49 (0)89 41 94 73 26
E-mail: [email protected]

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish